Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2007
03/29/2007CA2622698A1 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
03/29/2007CA2621720A1 Carbazole derivatives
03/29/2007CA2621062A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands
03/29/2007CA2619093A1 Modulators of metabolism and the treatment of disorders related thereto
03/29/2007CA2619068A1 Imidazole compounds for the treatment of neurological disorders
03/29/2007CA2615897A1 Compounds and methods for treatment of amyloid-beta-peptide related disorders
03/28/2007EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor
03/28/2007EP1767527A1 Method for producing cyclic diamine derivative
03/28/2007EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists
03/28/2007EP1765818A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use
03/28/2007EP1765812A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
03/28/2007EP1765810A1 2,4-diaminoquinazolines for spinal muscular atrophy
03/28/2007EP1765808A1 Bisarylurea derivatives useful for inhibiting chk1
03/28/2007EP1765807A1 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
03/28/2007EP1765806A1 New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
03/28/2007EP1765805A2 Cgrp receptor antagonists
03/28/2007EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/28/2007EP1765793A1 Cetp inhibitors
03/28/2007EP1765791A1 Pyrimidine derivatives useful as inhibitors of pkc-theta
03/28/2007EP1765790A1 Azine-carboxamides as anti-cancer agent
03/28/2007EP1765789A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
03/28/2007EP1765788A2 3-aminoindazole derivatives and their use for the treatment of sgk-associated diseases
03/28/2007EP1765784A2 Antibiotic cycloalkyltetrahydroquinoline derivatives
03/28/2007EP1765775A1 Indoles useful in the treatment of inflammation
03/28/2007EP1765327A2 Compounds, compositions and methods
03/28/2007CN1938314A Tetrahydroquinoline derivatives and a process for preparing the same
03/28/2007CN1938296A Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
03/28/2007CN1938294A Novel pyrrolidine-3,4-dicarboxamide derivatives
03/28/2007CN1938293A New compounds for the inhibition of angiogenesis and use of thereof
03/28/2007CN1938292A Cyclic amine compound and pest control agent
03/28/2007CN1938291A Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
03/28/2007CN1938283A Pyridazinones as antagonists of alpha4 integrins
03/28/2007CN1938281A Ion channel modulators
03/28/2007CN1938274A Novel piperidines as chemokine modulators (CCR)
03/28/2007CN1938273A Tetrahydrocarbazoles and derivatives
03/28/2007CN1938244A Fluoridation method
03/28/2007CN1938031A Biaryl substituted pyrazinones as sodium channel blockers
03/28/2007CN1938026A Controlled-release pharmaceutical composition and method for producing the same
03/28/2007CN1938022A Ion channel modulators
03/28/2007CN1938021A Ion channel modulators
03/28/2007CN1938020A Ion channel modulators
03/28/2007CN1935141A Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
03/28/2007CN1307172C 喹唑啉酮衍生物 Quinazolinone derivative
03/28/2007CN1307161C Substituted dihydro 3-hylo-1H-pyrazoloe-5-carboxylates their prepn. and use
03/28/2007CN1307159C TNF-alpha prodn. inhibitors
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/28/2007CN1307157C Novel compounds
03/28/2007CN1307156C Polyarylcarboxamides useful as lipid lowering agents
03/28/2007CN1307155C Deltal-pyrrolines used as pesticides
03/28/2007CN1306935C Vasopressin antagonist and oxytocin antagonist
03/27/2007US7196202 1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
03/27/2007US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis
03/27/2007US7196199 Phenoxypropylamine compounds
03/27/2007US7196195 8-chloro-6,11-dihydro-11-(4-piperidilydene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine); good solubility; anti-allergen
03/27/2007US7196110 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents
03/27/2007US7196103 Indole derivatives as factor Xa inhibitors
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
03/27/2007US7196100 Opioid receptor antagonists
03/27/2007US7196099 Compounds and compositions as cathepsin inhibitors
03/27/2007US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
03/27/2007US7196088 5-HT6 modulators; such as 2-benzenesulfonyl-5-piperazin-1-yl-1,2,3,4-tetrahydroisoquinoline;
03/27/2007US7196085 Phthalazinone derivatives
03/27/2007US7196080 Respiratory system disordeers; chronic obstructive pulminary disease
03/27/2007US7196079 for treating, headache, migraine or cluster headache
03/27/2007US7195751 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis
03/27/2007US7195649 N-aryl-4,5-diaminopyrazoles and dyes containing said compounds
03/27/2007CA2396874C 4-aminopicolinates and their use as herbicides
03/27/2007CA2370244C Piperidine derivatives
03/27/2007CA2326611C Substituted heterocyclic derivatives
03/27/2007CA2251820C Substituted benzylamines and their use for the treatment of depression
03/27/2007CA2208018C Sulfonamides
03/22/2007WO2007033196A1 Met kinase inhibitors
03/22/2007WO2007032936A2 Azafused cyclin dependent kinase inhibitors
03/22/2007WO2007032833A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
03/22/2007WO2007032572A1 N-substituted-1h-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same
03/22/2007WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
03/22/2007WO2007032445A1 Protein kinase inhibitors
03/22/2007WO2007032371A1 Oxindole derivative as feeding control agent
03/22/2007WO2007031845A2 Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
03/22/2007WO2007031828A2 Therapeutic pyrrolidines
03/22/2007WO2007031721A1 Midazole-4-carboxamide derivatives for use as cb modulators
03/22/2007WO2007031720A1 1,2-diarylimidazoles for use as cbi modulators
03/22/2007WO2007031529A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity
03/22/2007WO2007030939A2 Methods of modulating neurotrophin-mediated activity
03/22/2007WO2007006926A3 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
03/22/2007WO2006133904A3 Methods and intermediates for the preparation of optionally radio-labeled imatinib
03/22/2007WO2006129237A3 Novel piperidine carboxylic acid amide derivatives
03/22/2007WO2006129120A9 Benzotriazepinone derivatives
03/22/2007WO2006117609A3 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands
03/22/2007WO2006113468A3 Compositions of novel opioid compounds and method of use thereof
03/22/2007WO2006106432A8 4-arylpiperidine derivatives and use thereof for preparing a medicament for the treatment of cns disorders
03/22/2007WO2006060122A3 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
03/22/2007WO2005084395A3 Method of stabilization of functional nanoscale pores for device applications
03/22/2007WO2005072308A3 Cgrp receptor antagonists
03/22/2007US20070066823 CCR9 inhibitors and methods of use thereof
03/22/2007US20070066724 Bisazoquinolone pigments, processes for their preparation and their use
03/22/2007US20070066670 Substituted benzimidazoles and their use for inducing apoptosis
03/22/2007US20070066660 e.g. (5-chloro-6-trifluoromethyl-1H-benzimidazol-2-yl)[4-(pyridin-4-yloxy) phenyl]amine; tyrosine kinases receptor (such as TIE-2) inhibitor; anticarcinogenic, antiinflammatory agent; autoimmune diseases; rheumatoid arthritis, psoriasis, contact dermatitis, leukaemia, lung adenocarcinoma
03/22/2007US20070066655 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 1080